Stabilized therapeutic compositions and formulations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/568 (2006.01)

Patent

CA 2697160

The invention relates to pharmaceutically acceptable formulations comprising an active pharmaceutical ingredient such as androst-5-ene-3.beta., 17.beta.-diol, androst-5-ene- 3.beta.,7.beta., 17.beta.-triol or derivatives of either of these compounds and an air oxidizable excipient that have been stabilized with respect to efficacy. Use of the efficacy-stabilized formulations to treat a number of conditions or symptoms thereof, such as a symptom associated with exposure to radiation is described.

L'invention concerne des formulations pharmaceutiquement acceptables comprenant un principe pharmaceutique actif tel que androst-5-ène-3ß,17ß-diol, androst-5-ène-3ß,7ß,17ß-triol ou des dérivés de l'un quelconque de ces composés et d'un excipient oxydable à l'air et stabilisées quant à leur efficacité. L'utilisation des formulations stabilisées quant à leur efficacité pour traiter un grand nombre d'affections ou symptômes, tels qu'un symptôme associé à l'exposition à un rayonnement, est décrite.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Stabilized therapeutic compositions and formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stabilized therapeutic compositions and formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized therapeutic compositions and formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1786666

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.